Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Jul 15;25(14):2897–2901. doi: 10.1093/nar/25.14.2897

Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide.

H Dougan 1, J B Hobbs 1, J I Weitz 1, D M Lyster 1
PMCID: PMC146821  PMID: 9207040

Abstract

Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide were undertaken to evaluate a gamma ray emitting ODN ligand for thrombus imaging in vivo . Synthesis of the ODN was based on modified automatedbeta-cyanoethyl phosphoramidite chemistry with an organotin nucleoside (dU*) coupled to a thrombin binding aptamer sequence to give d(U*GGTTGGTGTGGTTGG). The synthesis accommodated dU*, which is destannylated by iodine or acids. Fourteen standard synthesis cycles were followed by one 'stannyl synthesis cycle', distinguished by Fmoc protection, omission of capping, oxidation by an organic peroxide and cleavage by ammonium hydroxide. The organotin nucleoside phosphoramidite ¿5'-[fluorenylmethoxycarbonyl]-5-(E)-[2-tri-n -butylstannylvinyl]-2'-deoxyuridine-3'-(2-cyanoethyl N,N-diisopropyl phosphoramidite)¿ was prepared from 5-iodo-2'-deoxyuridine. A customized mild rapid workup included deprotection with methylamine, and reverse phase HPLC with CH3CN/triethylammonium bicarbonate. Pure stannyl ODN was highly retained by reverse phase HPLC. Radioiodination of stannyl ODN (100 microg) provided 123I-labeling yields up to 97%. Five alternative oxidants were effective. High specific activity [123I]- ODN (15 000 Ci/mmol) was recovered, separated from unlabeled isomers. Excellent reverse phase HPLC resolution of ODN isomers (alternatively I, Cl, H or Br in vinyl deoxyuridine) was essential. The affinity of the iodovinyl aptamer analog (Kd = 36 nM) for human alpha-thrombin was similar to the native aptamer (Kd = 45 nM).

Full Text

The Full Text of this article is available as a PDF (81.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. M., Zea-Ponce Y., Zoghbi S. S., Laurelle M., al-Tikriti M. S., Sybirska E. H., Malison R. T., Neumeyer J. L., Milius R. A., Wang S. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol. 1993 Jul;20(5):597–606. doi: 10.1016/0969-8051(93)90028-s. [DOI] [PubMed] [Google Scholar]
  2. Bock L. C., Griffin L. C., Latham J. A., Vermaas E. H., Toole J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 1992 Feb 6;355(6360):564–566. doi: 10.1038/355564a0. [DOI] [PubMed] [Google Scholar]
  3. Bock P. E. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases. J Biol Chem. 1992 Jul 25;267(21):14974–14981. [PubMed] [Google Scholar]
  4. Boskovic D. S., Giles A. R., Nesheim M. E. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid. J Biol Chem. 1990 Jun 25;265(18):10497–10505. [PubMed] [Google Scholar]
  5. Commerford S. L. Iodination of nucleic acids in vitro. Biochemistry. 1971 May 25;10(11):1993–2000. doi: 10.1021/bi00787a005. [DOI] [PubMed] [Google Scholar]
  6. Connolly B. A. Synthetic oligodeoxynucleotides containing modified bases. Methods Enzymol. 1992;211:36–53. doi: 10.1016/0076-6879(92)11005-4. [DOI] [PubMed] [Google Scholar]
  7. Dale R. M., Ward D. C., Livingston D. C., Martin E. Conversion of covalently mercurated nucleic acids to tritiated and halogenated derivatives. Nucleic Acids Res. 1975 Jun;2(6):915–930. doi: 10.1093/nar/2.6.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. David G. S. Solid state lactoperoxidase: a highly stable enzyme for simple, gentle iodination of proteins. Biochem Biophys Res Commun. 1972 Jul 25;48(2):464–471. doi: 10.1016/s0006-291x(72)80074-3. [DOI] [PubMed] [Google Scholar]
  9. Dougan H., Rennie B. A., Lyster D. M., Sacks S. L. No-carrier-added [123I]1-(beta-D-arabinofuranosyl)-5(E)-(2- iodovinyl)uracil (IVaraU): high yield radiolabeling via organotin and exchange reactions. Appl Radiat Isot. 1994 Jul;45(7):795–801. doi: 10.1016/0969-8043(94)90131-7. [DOI] [PubMed] [Google Scholar]
  10. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  11. Gentry G. A. Viral thymidine kinases and their relatives. Pharmacol Ther. 1992;54(3):319–355. doi: 10.1016/0163-7258(92)90006-l. [DOI] [PubMed] [Google Scholar]
  12. Lehmann C., Xu Y. Z., Christodoulou C., Tan Z. K., Gait M. J. Solid-phase synthesis of oligoribonucleotides using 9-fluorenylmethoxycarbonyl (Fmoc) for 5'-hydroxyl protection. Nucleic Acids Res. 1989 Apr 11;17(7):2379–2390. doi: 10.1093/nar/17.7.2379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leung L. L. Application of combinatorial libraries and protein engineering to the discovery of novel anti-thrombotic drugs. Thromb Haemost. 1995 Jul;74(1):373–376. [PubMed] [Google Scholar]
  14. Ma Y., Sonveaux E. The 9-fluorenylmethyloxycarbonyl group as a 5'-OH protection in oligonucleotide synthesis. Biopolymers. 1989 May;28(5):965–973. doi: 10.1002/bip.360280505. [DOI] [PubMed] [Google Scholar]
  15. Markwell M. A. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem. 1982 Sep 15;125(2):427–432. doi: 10.1016/0003-2697(82)90025-2. [DOI] [PubMed] [Google Scholar]
  16. Nielsen J., Taagaard M., Marugg J. E., van Boom J. H., Dahl O. Application of 2-cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite for in situ preparation of deoxyribonucleoside phosphoramidites and their use in polymer-supported synthesis of oligodeoxyribonucleotides. Nucleic Acids Res. 1986 Sep 25;14(18):7391–7403. doi: 10.1093/nar/14.18.7391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Samuel J., Gill M. J., Iwashina T., Tovell D. R., Tyrrell D. L., Knaus E. E., Wiebe L. I. Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs. Antimicrob Agents Chemother. 1986 Feb;29(2):320–324. doi: 10.1128/aac.29.2.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Samuel J., Knaus E. E., Wiebe L. I., Tyrrell D. L. Synthesis of 131I, 125I and 82Br labelled (E)-5-(2-halovinyl)-2'-deoxyuridines. Int J Appl Radiat Isot. 1984 Nov;35(11):1049–1052. doi: 10.1016/0020-708x(84)90008-5. [DOI] [PubMed] [Google Scholar]
  19. Sawadogo M., Van Dyke M. W. A rapid method for the purification of deprotected oligodeoxynucleotides. Nucleic Acids Res. 1991 Feb 11;19(3):674–674. doi: 10.1093/nar/19.3.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schulhof J. C., Molko D., Teoule R. The final deprotection step in oligonucleotide synthesis is reduced to a mild and rapid ammonia treatment by using labile base-protecting groups. Nucleic Acids Res. 1987 Jan 26;15(2):397–416. doi: 10.1093/nar/15.2.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tanaka T., Letsinger R. L. Syringe method for stepwise chemical synthesis of oligonucleotides. Nucleic Acids Res. 1982 May 25;10(10):3249–3260. doi: 10.1093/nar/10.10.3249. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES